Physician profile
Sunil T Gupta
NPI 1437310059
$2,299.80
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,363 · 2020: $632 · 2021: $190 · 2022: $115.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $594.05 | 2019-2022 | |
| Abbvie INC. | $335.23 | 2019-2022 | |
| Celgene Corporation | $301.19 | 2019 | |
| Genzyme Corporation | $212.54 | 2019-2020 | |
| Pfizer INC. | $147.30 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $140.86 | 2019 | |
| Horizon Therapeutics Plc | $112.11 | 2019-2021 | |
| Glaxosmithkline, LLC. | $80.59 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.91 | 2019 | |
| Lilly USA, LLC | $48.30 | 2019 | |
| Alexion Pharmaceuticals, INC. | $42.68 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $41.81 | 2019-2020 | |
| Antares Pharma, INC. | $28.01 | 2019 | |
| Janssen Biotech, INC. | $25.66 | 2020 | |
| Novartis Pharmaceuticals Corporation | $22.81 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.06 | 2019 | |
| Vivus LLC | $21.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.49 | 2019 | |
| Gilead Sciences, INC. | $15.57 | 2020 | |
| Depuy Synthes Sales INC. | $14.71 | 2019 | |
| Merck Sharp & Dohme LLC | $14.32 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.